For many women pregnant after 35, non-invasive prenatal testing, or NIPT, is one of the first major screening decisions of the pregnancy. It’s often introduced quickly at an early appointment, sometimes without much explanation of what the results actually mean — and don’t mean. Understanding the basics can help you approach the test, and the conversation that follows it, with more clarity.
Part of what can make this test feel disorienting is the speed at which it’s introduced — often at a single early appointment, alongside a stack of other paperwork and decisions, well before many women have had time to fully process being pregnant in the first place. Slowing down and asking your provider to walk through exactly what the test does and doesn’t tell you, even if it means asking to revisit the conversation at a follow-up visit, is a reasonable request rather than an inconvenience.
Some practices now offer written materials or brief educational videos ahead of the appointment specifically to address this pacing problem, allowing patients to absorb the basics before being asked to make a decision on the spot. If your provider’s office doesn’t offer this, asking whether such resources exist, or requesting a few days to consider before scheduling the blood draw, is a completely reasonable way to approach the decision at your own pace. There is no clinical downside to taking a short amount of extra time to feel confident in your decision, since the standard testing window typically spans several weeks of early pregnancy.
What Research Shows About NIPT Accuracy
NIPT analyzes small fragments of placental DNA circulating in the mother’s blood to screen for certain chromosomal conditions, most commonly trisomy 21, 18, and 13. According to the American College of Obstetricians and Gynecologists, NIPT has high detection rates for these conditions, particularly trisomy 21, though it is a screening test, not a diagnostic one — meaning a positive result indicates increased likelihood, not certainty.
Why NIPT Is a Screening Test, Not a Diagnosis
This distinction matters enormously and is sometimes lost in how results are communicated. A “high risk” NIPT result means the statistical likelihood of a condition is elevated based on the DNA fragments analyzed, but confirming a diagnosis requires a diagnostic test such as chorionic villus sampling or amniocentesis. False positives can occur, sometimes related to placental mosaicism or other biological factors unrelated to the fetus itself, which is why providers generally recommend diagnostic confirmation before making significant decisions based on NIPT results alone.
Why Providers Often Recommend NIPT After 35
Because the likelihood of certain chromosomal conditions increases with maternal age, NIPT is commonly offered or recommended to women having a baby after 35 as part of routine prenatal care. It’s worth noting that professional guidelines increasingly support offering NIPT to women of any age who want the information, not solely based on an age threshold, reflecting a broader shift toward patient choice in prenatal screening decisions.
What NIPT Can and Can’t Tell You
Beyond the standard trisomies, some NIPT panels also screen for sex chromosome differences and, less reliably, certain microdeletions, though the evidence supporting the latter is generally weaker and false positive rates can be higher. NIPT cannot detect structural abnormalities, which is part of why it’s typically used alongside, not instead of, ultrasound-based screening such as the anatomy scan and nuchal translucency measurement.
Processing Results and Next Steps
Receiving an unexpected NIPT result, whether high-risk or inconclusive, can understandably bring up significant anxiety. Genetic counselors are specifically trained to help interpret these results in context, explain the actual statistical likelihood involved, and walk through diagnostic testing options if you choose to pursue them. Many hospitals and prenatal practices offer access to genetic counseling as part of standard care after an abnormal screening result, and asking your provider about this resource is a reasonable next step.
NIPT and the Broader Landscape of Prenatal Screening Choices
NIPT is one option within a menu of first-trimester screening choices, and providers generally present it alongside alternatives like combined first-trimester screening (which pairs blood markers with the nuchal translucency ultrasound) and second-trimester quad screening. Each approach has different detection rates, timing windows, and cost and insurance considerations, and no single option is universally “better” — the right choice depends on personal values, prior pregnancy history, and what kind of information feels useful to have during pregnancy.
Some women choose to decline all prenatal genetic screening entirely, which is a fully legitimate choice that does not affect the medical care they otherwise receive during pregnancy. Others want as much information as early as possible. There is no universally correct answer, and providers who specialize in prenatal care are generally well-equipped to walk through the trade-offs of each option in the context of your specific pregnancy and personal preferences, without pressure toward any particular choice.
Insurance coverage for NIPT also varies, and some plans only cover the test for patients meeting certain risk criteria, such as advanced maternal age. Checking with your insurance provider ahead of testing, and asking your clinic’s billing office about estimated out-of-pocket costs, can help you avoid an unexpected bill and factor cost into your decision-making alongside the clinical considerations.
Frequently Asked Questions
Is NIPT the same as a diagnostic genetic test?
No. NIPT is a screening test that estimates likelihood based on placental DNA fragments in the mother’s blood. Diagnostic confirmation requires a separate test such as CVS or amniocentesis.
How accurate is NIPT for detecting Down syndrome?
NIPT has a high detection rate for trisomy 21 in published studies, though rates vary somewhat by lab and specific condition. Even with high accuracy, a positive result should be confirmed with diagnostic testing.
Can NIPT give a false positive result?
Yes, false positives can occur, sometimes due to placental mosaicism or other biological factors unrelated to the fetus. This is one reason diagnostic testing is recommended before major decisions are made.
Do I need NIPT if I’m having a baby after 35?
NIPT is commonly offered to women of advanced maternal age, but it remains an optional test. Discussing your personal risk factors and preferences with your provider can help you decide whether it’s right for you.
Will my insurance cover NIPT?
Coverage varies by plan and sometimes depends on meeting specific risk criteria. Checking with your insurance provider and your clinic’s billing office beforehand can help you understand any potential out-of-pocket cost.
Key Takeaways
- NIPT screens for chromosomal conditions using placental DNA in maternal blood and has high detection rates for common trisomies.
- A positive NIPT result indicates increased likelihood, not a confirmed diagnosis, and should be followed by diagnostic testing if pursued.
- NIPT cannot detect structural abnormalities and is typically used alongside ultrasound-based screening.
- Genetic counseling is available to help interpret results and discuss next steps after an unexpected finding.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.